Shankara Pharmaceuticals Private Limited
About Shankara Pharmaceuticals Private Limited
Data last updated:
Shankara Pharmaceuticals Private Limited was a private limited company based in Chittoor, Andhra Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the manufacturing segment of the food and beverages sector. It was incorporated on 16 May 2017.
The company was registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24304AP2017PTC105836.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Surendra Babu Koracha Narasimha (Managing Director) and Sulochana Bijili.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at C Yellagram Venkatagirikota, Chittoor, Andhra Pradesh, India – 517424.
Company details
Contact details
Shankara Pharmaceuticals Private Limited's registered office is in Chittoor, Andhra Pradesh.
- Registered AddressC Yellagram Venkatagirikota, Chittoor, Andhra Pradesh, India – 517424
- IndustryFood and Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shankara Pharmaceuticals Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Shankara Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shankara Pharmaceuticals Private Limited
Shankara Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendra Babu Koracha Narasimha | Managing Director | 16 May 2017 | 9 Years 5 Months | As last reported |
| Sulochana Bijili | Director | 16 May 2017 | 9 Years 5 Months | As last reported |
Legal cases
No court or tribunal cases involving Shankara Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shankara Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shankara Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shankara Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Sulochana Bijili was appointed as Director on 16 May 2017.
Frequently asked questions
Shankara Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Shankara Pharmaceuticals was a private limited company based in Chittoor, Andhra Pradesh, India. The company worked in manufacturing, within the food and beverages industry. It was incorporated on 16 May 2017 and is registered under CIN U24304AP2017PTC105836. The company has been struck off by the Registrar of Companies and is no longer operational.
Shankara Pharmaceuticals had 2 directors:
- Surendra Babu Koracha Narasimha - Managing Director
- Sulochana Bijili - Director
The CIN (Corporate Identification Number) of Shankara Pharmaceuticals is U24304AP2017PTC105836. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Shankara Pharmaceuticals is at C Yellagram Venkatagirikota, Chittoor, Andhra Pradesh, India – 517424.
Shankara Pharmaceuticals was incorporated on 16 May 2017. It is registered with the Registrar of Companies, Vijayawada.
The latest financial statements of Shankara Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2018 are in the company report.
Shankara Pharmaceuticals operated in the food and beverages industry, in the manufacturing segment. It worked in this industry before it was struck off.
Sulochana Bijili was appointed as Director on 16 May 2017. Surendra Babu Koracha Narasimha was appointed as Managing Director on 16 May 2017.
The compliance status of Shankara Pharmaceuticals is compliant as of 19 July 2026.